64 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • China Finance Online Co. Limited JRJC shares jumped 233.7% to $24.39 after the company announced an agreement under which Dow Jones will provide the company with access to a sub-set of its Chinese language newswire service.
  • Taiwan Liposome Company, Ltd. TLC shares climbed 78.7% to $11.13 after the company reported that a pre-print version of a manuscript on TLC’s strategy to treat coronavirus disease with targeted delivery of inhalable liposomal hydroxychloroquine has been made publicly available.
  • Genetic Technologies Limited GENE gained 69.6% to $3.8321 after the company issued an update on its COVID-19 Severity Risk Test.
  • Immutep Limited IMMP climbed 69.1% to $1.86 after the company announced United States patent grant for IMP701 antibody.
  • Capitala Finance Corp. CPTA rose 43% to $2.93 after the company disclosed portfolio activity for the second quarter. During the quarter, the company received more than $51.1 million in repayments from its portfolio companies.
  • Moleculin Biotech Inc MBRX climbed 42.7% to $1.12 after the company announce an agreement to produce its WP1122 for the expanded development of a potential coronavirus and oncology drug candidate.
  • EDAP TMS S.A. EDAP surged 37.8% to $3.28 after the company reported recent Focal One sales successes.
  • Leju Holdings Limited LEJU shares rose 34.5% to $3.496 after the company filed its annual report on Form 20-F.
  • Bloom Energy Corporation BE climbed 27% to $16.62 after the company outlined initial strategy for hydrogen market entry.
  • Equillium, Inc. EQ rose 26.4% to $17.67. Equillium shares dipped 47% on Tuesday after the company filed a prospectus supplement related to a common stock offering of up to $150 million.
  • NextDecade Corporation NEXT gained 24.7% to $2.13. NextDecade said it is reducing CO2e emissions by optimizing its Rio Grande LNG project.
  • Origin Agritech Limited SEED surged 22.4% to $11.20.
  • Key Tronic Corporation KTCC climbed 22.2% to $7.33. Keytronic disclosed that it has been selected by Manufacturing Technology Insights Magazine as a Top 10 Contract Manufacturing Service Provider for 2020.
  • Acorda Therapeutics, Inc. ACOR shares rose 22% to $0.8534 after the company said it received a US income tax refund from the IRS of roughly $12.7 million.
  • VBI Vaccines Inc. VBIV rose 19.8% to $5.40 after climbing around 19% on Tuesday.
  • Dave & Buster's Entertainment, Inc. PLAY rose 19.7% to $13.88.
  • Organogenesis Holdings Inc ORGO surged 18.3% to $3.89 after the company issued strong Q2 sales forecast.
  • Galmed Pharmaceuticals Ltd. GLMD rose 17.8% to $5.56.
  • Royal Caribbean Cruises Ltd. RCL surged 16% to $55.91 after a company working on a coronavirus vaccine announced positive phase 1 trial results, giving investors hope that normal economic activity will resume.
  • Atossa Therapeutics, Inc. ATOS gained 16% to $4.1499 following co. press release highlighting successful in vitro testing of nasal spray formulation.
  • Waters Corporation WAT gained 15.5% to $228.78 after the company announced a new CEO who recently held leadership positions at Merck.
  • RTI Surgical Holdings, Inc. RTIX surged 15.5% to $3.9150.
  • Forescout Technologies, Inc. FSCT rose 15.4% to $28.90. Forescout and Advent reported an amended merger deal.
  • Everi Holdings Inc. EVRI shares climbed 15% to $6.28 amid overall market strength following positive coronavirus vaccine developments.
  • Infosys Limited INFY gained 14.7% to $12.15 after the company reported quarterly results.
  • Retractable Technologies, Inc. RVP gained 14.8% to $8.64.
  • Mitcham Industries, Inc. MIND rose 14.7% to $2.5571.
  • ESSA Pharma Inc. EPIX surged 14% to $6.85 after the company disclosed that the first patient dosed in a Phase 1 clinical trial of EPI-7386 for metastatic castration-resistant prostrate cancer.
  • Red Robin Gourmet Burgers, Inc. RRGB surged 13.7% to $8.51 amid overall market strength following positive coronavirus vaccine developments.
  • Moderna, Inc. MRNA shares rose 13.1% to $84.84 after the company issued a positive update on its coronavirus vaccine. Moderna's vaccine drug "induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified. The company also said it remains on track to deliver approximately 500 million doses of the vaccine per year beginning in 2021.
  • IMAX Corporation IMAX gained 13.1% to $12.74 amid overall market strength following positive coronavirus vaccine developments. A successful vaccine could lead to a sooner rebound in restaurant traffic and an easing of capacity restrictions.
  • Norwegian Cruise Line Holdings Ltd. NCLH rose 12.8% to $17.29 on heels of positive Moderna vaccine news.
  • Braemar Hotels & Resorts, Inc. BHR rose 11.6% to $2.8450 after declining around 5% on Tuesday.
  • Hanesbrands Inc. HBI gained 11.6% to $14.00 after Raymond James upgraded the stock from Market Perform to Strong Buy and announced a price target of $20 per share.
  • Global Eagle Entertainment Inc. ENT climbed 11.5% to $3.89.
  • Wipro Limited WIT gained 10.9% to $3.87. The company on Tuesday reported better-than-expected Q1 results.
  • Oramed Pharmaceuticals, Inc. ORMP climbed 10.3% to $3.96 after the company reported the positive end of its Phase 2 meeting with the FDA for its Oral Insulin.
  • Can-Fite BioPharma Ltd. CANF gained 9.5% to $2.0150 after the company announced it has completed its Phase 2 COVID-19 study protocol based on FDA guidance. The company also announced it plans to file an IND application with its completed protocol before the end of July.
  • Soliton Inc SOLY gained 9.2% to $8.34 after the company received FDA acceptance for 510(k) application.
  • Celsion Corporation CLSN shares rose 8.8% to $1.36. Celsion is expected to host a conference call today to discuss its current observations about the results of the OPTIMA study and its next steps.
  • American Airlines Group Inc. AAL rose 8.5% to $12.56 on heels of positive Moderna vaccine news.
  • Morphosys Ag MOR gained 8.4% to $34.66 after the company's treatment for Psoriatic Arthiritis was approved by the FDA.
  • TherapeuticsMD, Inc. TXMD surged 8.1% to $1.61 after the company announced an arrangement to expand access to ANNOVERA to Nurx's 300,000 patients across the country.
  • iBio, Inc. IBIO rose 7.1% to $2.4850 after gaining over 5% on Tuesday.
  • AstraZeneca PLC AZN gained 6% to $57.12 after the company announced its collaboration with IQVIA to accelerate the development of a potential new vaccine for COVID-19.


Check out these big penny stock gainers and losers

Losers

  • Perceptron, Inc. PRCP shares dropped 26.3% to $4.79. Perceptron shares surged 107% on Tuesday after the company received an order from an automotive supplier for its in-line measurement technology.
  • Cleveland BioLabs, Inc. CBLI shares fell 23.2% to $2.5102 after surging more than 57% on Tuesday.
  • Rigel Pharmaceuticals, Inc. RIGL fell 21.8% to $3.2250. Rigel Pharmaceuticals shares rose 91% on Tuesday after the company announced the launch of an investigator-sponsored trial of Fostamatinib for the treatment of COVID-19 pneumonia.
  • Caladrius Biosciences, Inc. CLBS dropped 18.3% to $2.4527.
  • Sphere 3D Corp. ANY fell 18% to $3.8115 after the company announced the acquisition of Rainmaker Worldwide.
  • Vaxart, Inc. VXRT dropped 17.4% to $14.02.
  • Altimmune, Inc. ALT fell 16.9% to $24.12. On Tuesday, Altimmune reported pricing of a public offering of $115 million of common stock and pre-funded warrants.
  • Sorrento Therapeutics, Inc. SRNE dropped 16.6% to $6.62.
  • Qumu Corporation QUMU shares declined 15% to $4.38. Qumu said it sees preliminary 2020 sales of $29 million.
  • MICT, Inc. MICT dropped 14.9% to $2.40.
  • Future FinTech Group Inc. FTFT fell 14.3% to $2.64 after rising over 27% on Tuesday.
  • AquaBounty Technologies, Inc. AQB dropped 12.6% to $3.81.
  • INmune Bio, Inc. INMB fell 12% to $13.87. INmune Bio shares jumped 78% on Tuesday following a positive clinical readout from the company.
  • IMV Inc. IMV fell 11.1% to $4.11. IMV shares gained 54% on Tuesday after the company issued an update on progress of COVID-19 vaccine program.
  • Marinus Pharmaceuticals, Inc. MRNS dropped 10.5% to $1.808.
  • Zynex, Inc. ZYXI fell 10.2% to $23.58 after the company announced a proposed common stock offering of 2.5 million shares at $22 per share.
  • Endologix, Inc. ELGX fell 8.6% to $0.2642. WiMi Endologix, last week, received a letter from Nasdaq indicating its common stock will be delisted..
  • CVD Equipment Corporation CVV shares fell 8% to $3.10. On Tuesday, CVD Equipment reported that its CVD Materials unit will collaborate with Dymax and Keyence to Accelerate development of company’s novel c-VACNT extracorporeal membrane oxygenation platform.
  • Bank of New York Mellon Corp BK dropped 7% to $36.24 following Q2 results.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksIntraday UpdateMarketsMoversTrading IdeasBiotechnologyEnergyHealth CareIntegrated Telecommunication ServicesMid-Day MoversOil & Gas Exploration & ProductionTelecommunication ServicesTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!